Effect of cilazapril and salt on Ca2+ extrusion in arterial smooth muscle of Dahl rats

American Journal of Hypertension

Volumn 10, Issue 5 II SUPPL., 1997, Pages

  Ashida, Terunao ^a,b   Yoshimi, Hiroki ^a,b   Kawano, Yuhei ^a,b   Matsuoka, Hiroaki ^a,b   Omae, Teruo ^a,b  

^a INSTITUTE FOR ADULT DISEASES   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

angiotensin converting enzyme inhibitor; ATP driven Ca pump; Dahl salt sensitive rats; dietary salt; Na Ca exchange

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CAFFEINE; CALCIUM ION; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHENTOLAMINE; VERAPAMIL;

ANIMAL MODEL; ARTERY MUSCLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONFERENCE PAPER; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SODIUM CALCIUM EXCHANGE;

EID: 0030921105     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(97)90017-0     Document Type: Conference Paper

References (29)

1. Prior IAM, Evans JG, Harvey HPB, et al. Sodium intake and blood pressure in two Polynesian populations. N Engl J Med. 279:1968;515-520.
2. Dahl LK. The possible role of chronic excess salt consumption in the pathogenesis of essential hypertension. Am J Cardiol. 8:1961;571-575.
3. MacGregor GA. Sodium is more important than calcium in essential hypertension. Hypertension. 7:1985;628-637.
4. INTERSALT: an international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. Br Med J. 297:1988;319-328.
5. Dahl LK, Heine M, Tassinari L. Effects of chronic excess salt ingestion: evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med. 115:1962;1173-1190.
6. Dahl LK, Heine M, Tassinari L. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature. 194:1962;480-482.
7. Rapp JP. Dahl salt-susceptible and salt resistant rats - a review. Hypertension. 4:1982;753-763.
8. Carafoli E. Intracellular calcium homeostasis. Ann Rev Biochem. 56:1987;395-433.
9. 2+-transport ATPases of vascular smooth muscle. Circ Res. 62:1988;266-278.
10. Blaustein MP. Sodium/calcium exchange in cardiac smooth and skeletal muscle: key to the control of contractility. Curr Top Membr Transport. 34:1989;289-330.
11. Reuter H, Blaustein MP, Haeusler G. Na-Ca exchange and tension development in arterial smooth muscle. Philos Trans R Soc Lond Biol. 265:1973;87-94.
12. Ashida T, Blaustein MP. Regulation of cell calcium and contractility in mammalian arterial smooth muscle: the role of sodium-calcium exchange. J Physiol (Lond). 392:1987;617-635.
13. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol. 232:1977;C165-C173.
14. Ashida T, Kuramochi M, Omae T. Increased sodium-calcium exchange in arterial smooth muscle of spontaneously hypertensive rats. Hypertension. 13:1989;890-895.
15. + exchange process in isolated sarcolemmal membranes of mesenteric arteries from WKY and SHR. Am J Physiol. 249:1985;C166-C172.
16. ++ influx in SHR vascular smooth muscle cells (abst). Circulation. 76:((suppl IV)):1987;IV130.
17. Lategan TW. Sodium/calcium exchange and hypertension. Kwan CY. Membrane Abnormalities in Hypertension. 1980;CRC Press, Boca Raton, Florida.
18. Kwan CY. Dysfunction of calcium handling by smooth muscle in hypertension. Can J Physiol Pharmacol. 63:1985;366-374.
19. Kwan CY, Triggle CR, Grover AK, Daniel EE. Subcellular membrane properties in vascular and nonvascular smooth muscles of Dahl hypertensive rats. J Hypertens. 4:1986;49-55.
20. Sharma JN, Fernandez PG, Kim BK, et al. Cardiac regression and blood pressure control in the Dahl rat treated with either enalapril maleate (MK 421, an angiotensin converting enzyme inhibitor) or hydrochlorothiazide. J Hypertens. 1:1983;251-256.
21. Fernandez D, Bolli P, Snedden W, et al. Modulation of left ventricular hypertrophy by dietary salt and inhibition of angiotensin converting enzyme. J Hypertens. 6:((suppl 4)):1988;S145-S147.
22. Peeler TC, Baker KM, Esmurdoc CF, Chernin MI. Angiotensin converting enzyme inhibition in Dahl salt-sensitive rats. Mol Cell Biochem. 104:1991;45-50.
23. Sharma JN, Fernandez PG, Kim BK, Triggle CR. Systolic blood pressure responses to enalapril maleate (MK 421, an angiotensin converting enzyme inhibitor) and hydrochlorothiazide in conscious Dahl salt-sensitive and salt-resistant rats. Can J Physiol Pharmacol. 62:1984;846-849.
24. von Lutterotti N, Camargo MJF, Mueller FB, et al. Angiotensin II receptor antagonist markedly reduces mortality in salt-loaded Dahl S rats. Am J Hypertens. 4:1991;346S-349S.
25. Popescu LM, Hinescu ME, Musat S, et al. Inositol triphosphate and the contraction of vascular smooth muscle cells. Eur J Pharmacol. 123:1986;167-169.
26. 2+ exchange in cultured vascular smooth muscle cells. Circ Res. 62:1988;486-493.
27. 2+ antiport in cultured arterial smooth muscle cells. J Biol Chem. 262:1987;11988-11994.
28. 2+ exchange in aortic muscle cells. Am J Physiol. 256:((Cell Physiol)):1989;C147-C154.
29. Hashimoto T, Hirata M, Itoh T, et al. Inositol 1,4,5-triphosphate activates pharmacomechanical coupling in smooth muscle of the rabbit mesenteric artery. J Physiol. 370:1986;605-618.